Vertex is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious and life-threatening diseases. We discovered and developed th...
Vertex is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious and life-threatening diseases. We discovered and developed the first medicines to treat the underlying cause of cystic fibrosis (CF), a rare, life-threatening genetic disease. In addition to clinical development programs in CF, Vertex has more than a dozen ongoing research programs focused on the underlying mechanisms of other serious diseases. Founded in 1989 in Cambridge, Massachusetts, our corporate headquarters is now located in Boston's Innovation District, and our international headquarters is in London, United Kingdom. We currently employ 2,100 people in the United States, Europe, Canada and Australia with nearly two-thirds of our staff dedicated to research and development. Vertex is consistently recognized as one of the industry's top places to work by Science magazine, The Boston Globe, Boston Business Journal and the San Diego Business Journal. Our research and medicines have also received esteemed recognitions, including the Robert J. Beall Therapeutics Development Award, the Fench Prix Galien and the British Pharmacological Society awards.
Public Symbol
VRTX
Founded Year
1989
Organization Website
vrtx.com
Organization Languages
English
Organization Revenue
1700000
Alexa Ranking
146225
Current Technologies
amazon cloudfront
salesforce
amazon elastic load balancer
marketo
jquery 2 1 1
google analytics
google async
recaptcha
omniture adobe
google adsense
asp net
vimeo
openssl
drupal
google tag manager
kenexa
apache
mobile friendly
addthis
Job Functions
Operations
Engineering
Marketing
Human Resources
Finance
Business Development
Accounting
Education
Legal
Media And Commmunication
Information Technology
Administrative
Consulting
Sales
Support
Product Management
Data Science
Arts And Design
alpha1 antitrypsin deficiency
sickle cell disease
adrenoleukodystrophy
continuous processing
polycystic kidney disease
cystic fibrosis
small molecule
solid oral dosage form
structurebased drug design
pharmaceuticals
biotechnology
pharmaceutical
medical
Shirley-Anne Mitchell's Work History and Education